Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00176423
Show Display Options
Download search resultsDownload the search results for:
NCT00176423 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: galantamine

Study has passed its completion date and status has not been verified in more than two years.